Free Trial
OTCMKTS:TSNDF

TerrAscend 11/9/2023 Earnings Report

TerrAscend logo
$0.93 -0.01 (-1.19%)
As of 09:56 AM Eastern

TerrAscend EPS Results

Actual EPS
-$0.04
Consensus EPS
-$0.02
Beat/Miss
Missed by -$0.02
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$89.24 million
Expected Revenue
$83.24 million
Beat/Miss
Beat by +$6.00 million
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

TerrAscend Reports Second Quarter 2025 Financial Results
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel
TerrAscend Announces Results of Annual General Meeting
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat